Caffeine and the anticonvulsant potency of antiepileptic drugs: Experimental and clinical data

Pharmacological Reports

Volumn 63, Issue 1, 2011, Pages 12-18

  Chrościńska Krawczyk, Magdalena ^a   Jargiełło Baszak, Małgorzata ^a   Wałek, Magdalena ^a   Tylus, Bozydar ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Caffeine; Epilepsy; Methylxanthines; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CAFFEINE; CARBAMAZEPINE; DIAZEPAM; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; METHYLXANTHINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ABSENCE; ANTICONVULSANT ACTIVITY; ATONIC SEIZURE; CLONIC SEIZURE; COFFEE; CONVULSION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG POTENTIATION; EPILEPSY; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; MYOCLONUS SEIZURE; NONHUMAN; REVIEW; TONIC CLONIC SEIZURE;

EID: 79953184352     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70394-2     Document Type: Review

References (56)

1. Bahi N, Nehlig A, Evrard P, Gressens P: Caffeine does not affect excitotoxic brain lesions in newborn mice. Eur J Paediatr Neurol, 2001, 5, 161-165. (Pubitemid 32694589)
2. Bernstein GA, Carroll ME, Thuras PD, Cosgrove KP, Roth ME: Caffeine dependence in teenagers. Drug Alcohol Depend, 2002, 66, 1-6. (Pubitemid 34159249)
3. Błaszczyk B: Caffeine and management of epilepsy - a clinical evidence. Pharmacol Rep, 2007, 59, 116.
4. Bonilha L, Li M: Heavy coffee drinking and epilepsy. Seizure, 2004, 13, 284-285. (Pubitemid 38607559)
5. Borowicz K, Kozicka M, Kleinrok Z, Czuczwar SJ: Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenylhydantoin, phenobarbital, and valproate against maximal electroshock- induced convulsions in mice. J Neural Transm, 1991, 86, 127-134.
6. Brown RA, Spina D, Page CP: Adenosine receptors and asthma. Br J Pharmacol, 2008, 153, 446-456.
7. Butanda-Ochoa A, Höjer G, Morales-Tlalpan V, Diaz-Muñoz M: Recognition and activation of ryanodine receptors by purines. Curr Med Chem, 2006, 13, 647-657.
8. Chrościńska M, Jargiełło M, Czuczwar SJ: Influence of caffeine on the protective action of some conventional and novel antiepileptic drugs - an experimental evidence. Pharmacol Rep, 2007, 59, 118.
9. Chrościńska-Krawczyk M, Ratnaraj N, Patsalos PN, Czuczwar SJ: Effect of caffeine on the anticonvulsant effects of oxcarbazepine, lamotrigine, and tiagabine in a mouse model of generalized tonic-clonic seizures. Pharmacol Rep, 2009, 61, 819-826.
10. Chu NS: Caffeine- and aminophylline-induced seizures. Epilepsia, 1981, 22, 85-94.
11. Cutrufo C, Bortot L, Giachetti A, Manzini S: Different effects of various xanthines on pentylenetetrazole-induced seizures in rats: An EEG and behavioural study. Eur J Pharmacol, 1992, 222, 1-6.
12. Czapiński P, Błaszczyk B, Czuczwar SJ: Mechanisms of action of antiepileptic drugs. Curr Top Med Chem, 2005, 5, 3-14. (Pubitemid 40202106)
13. Czuczwar SJ, Ga̧sior M, Janusz W, Szczepanik B, Włodarczyk D, Kleinrok Z: Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia, 1990, 31, 318-323. (Pubitemid 20181302)
14. Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski W: Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia, 1986, 27, 204-208. (Pubitemid 16065360)
15. Czuczwar SJ, Janusz W, Szczepanik B, Kleinrok Z: Influence of CGS 15943A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice. J Neural Transm, 1991, 86, 127-134.
16. Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z: Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol, 1987, 144, 309-315. (Pubitemid 18019803)
17. Czuczwar SJ, Jäckel R, Löscher W: Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdale-kindled seizures in rats. Epilepsy Res, 1987, 1, 234-238. (Pubitemid 17162356)
18. Czuczwar SJ, Kleinrok Z: Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients. Pharmacol Res, 1990, 22, 661-665.
19. Czuczwar SJ, Patsalos PN: The new generation of GABA enhancers. Potential in the treatment of epilepsy. CNS Drugs, 2001, 15, 339-350.
20. Daly JW, Butts-Lamb P, Padgett W: Subclasses of adenosine receptors in the central nervous system: Interactions with caffeine and related methylxanthines. Cell Moll Neurobiol, 1983, 3, 69-80. (Pubitemid 13014444)
21. De Sarro G, De Sarro A, Di Paola ED, Bertorelli R: Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol, 1999, 371, 137-145. (Pubitemid 29216995)
22. Dingledine R, McBain C, McNamara JO: Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci, 1990, 11, 334-338. (Pubitemid 20240665)
23. Dworetzky BA, Bromfield EB, Townsend MK, Kang JH: A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: data from the Nurses' Health Study II. Epilepsia, 2010, 51, 198-205.
24. Fredholm BB, Lizerman AP, Jacobson KA, Klotz K-N, Linden J: International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev, 2001, 53, 527-552.
25. Ga̧sior M, Borowicz KK, Buszewicz G, Kleinrok Z, Czuczwar SJ: Anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice during chronic treatment with caffeine and caffeine discontinuation. Epilepsia, 1996, 37, 262-268. (Pubitemid 26075445)
26. Ga̧sior M, Borowicz KK, Kleinrok Z, Czuczwar SJ: Chronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock. Pharmacol Biochem Behav, 1996, 54, 639-644. (Pubitemid 26258643)
27. 2+ channel modulators against experimental seizures in mice. Eur J Pharmacol, 1998, 352, 207-214.
28. Gilbert RM, Marshman JA, Schwieder M, Berg R: Caffeine content of beverages as consumed. Can Med Assoc J, 1976, 114, 205-207.
29. Goto M, Morishita S, Fukuda H: Anticonvulsant action of diazepam in mice pretreated with caffeine. J Pharmacobiodyn, 1983, 6, 654-659. (Pubitemid 14237911)
30. 2A receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett, 2002, 329, 289-292.
31. Jankiewicz K, Chrościńska-Krawczyk M, Błaszczyk B, Czuczwar SJ: Caffeine and antiepileptic drugs: experimental and clinical data (Polish). Przegl Lek, 2007, 64, 965-967.
32. Kaufman K, Sachdeo R: Caffeinated beverages and decreased seizure control. Seizure, 2003, 12, 519-521. (Pubitemid 37168643)
33. Koryntová H, Kubová H, Tutka P, Mares P: Changes of cortical epileptic afterdischarges under the influence of convulsant drugs. Brain Res Bull, 2002, 58, 49-54. (Pubitemid 34732995)
34. Kulkarni C, Joseph T, David J: Influence of adenosine receptor antagonists, aminophylline and caffeine, on seizure protective ability of antiepileptic drugs in rats. Indian J Exp Biol, 1991, 29, 751-754.
35. Kumar V, Sharma A: Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol, 2009, 616, 7-15.
36. Londos C, Cooper D, Wolff J: Subclasses of external adenosine receptors. Proc Natl Acad Sci USA, 1980, 77, 2551-2554. (Pubitemid 10049819)
37. Löscher W, Schimdt D: Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res, 1988, 2, 145-181.
38. Łuszczki JJ, Zuchora M, Sawicka KM, Kozińska J, Czuczwar SJ: Acute exposure to caffeine decreases the anticonvulsant action of ethosuximide, but not clonazepam, phenobarbital and valproate against pentetrazole-induced seizures in mice. Pharmacol Rep, 2006, 58, 652-659.
39. Margineau DG, Klitgaard H: Caffeine-induced epileptiform field potentials in rat hippocampal slices: a pharmacological characterization. Neuropharmacology, 2004, 47, 926-934.
40. 3 neurons of hippocampal slices (guinea pig). Brain Res, 1994, 640, 140-145.
41. Murray TF, Zhang G, Franklin PH: Manipulation of endogenous adenosine affects seizure susceptibility. Drug Dev Res, 1992, 28, 410-415. (Pubitemid 23112034)
42. Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA: Which seizure-precipitating factors do patients with epilepsy most frequently report? Epilepsy Behav, 2005, 6, 85-89.
43. Neering IR, McBurney RN: Role for microsomal Ca storage in mammalian neurons? Nature, 1984, 309, 158-160.
44. Nehlig A, Daval JL, Debry G: Caffeine and the central nervous system: Mechanism of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev, 1992, 17, 139-170.
45. Perucca E: An introduction to antiepileptic drugs. Epilepsia, 2005, 46, Suppl 4, 31-37.
46. 2A adenosine receptors of piriform cortex in amygdala-kindled rats. Can J Physiol Pharmacol, 2007, 85, 606-612.
47. Rum L: Coffee - Legend, History (Polish), WKolorach Tȩczy Publisher, Wrocław, 2000.
48. 2 adenosine receptors. Naunyn- Schmiedeberg's Arch Pharmacol, 1985, 330, 212-221.
49. Sebastiao AM, Ribeiro JA: Adenosine A2 receptor mediated excitatory action on the nervous system. Prog Neurobiol, 1996, 48, 167-189. (Pubitemid 26161859)
50. Shi D, Nikodijevic O, Jacobson KA, Daly J: Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain. Cell Mol Neurobiol, 1993, 13, 247-261. (Pubitemid 23283679)
51. Svennigsson P, Hall H, Sedval G, Fredholm BB: Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse, 1997, 27, 322-335. (Pubitemid 27479470)
52. Tchekalarova J, Kubova H, Mares P: Postanatal caffeine treatment affects differently two pentylenetetrazol seizure models in rats. Seizure, 2009, 18, 463-469.
53. Vianna EP, Ferreira AT, Dona F, Cavalheiro EA, da Silva Fernandes MJ: Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats. Epilepsia, 2005, 46, Suppl 5, 166-173.
54. 3 receptors stimulation on seizures in mice. Eur J Pharmacol, 1995, 275, 23-29.
55. 1 region have opposite effects on piriform cortex kindled seizures in rats. Seizure, 2006, 15, 41-48.
56. Zwillich CW, Sutton FD, Neff TA, Cohn WM, Matthay RA, Weinberger MM: Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med, 1975, 82, 784-787.